» Articles » PMID: 12837517

Dopamine-induced Oxidative Stress in Neurons with Glutathione Deficit: Implication for Schizophrenia

Overview
Journal Schizophr Res
Specialty Psychiatry
Date 2003 Jul 3
PMID 12837517
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Glutathione (GSH) is the main non-protein antioxidant and plays a critical role in protecting cells from damage by reactive oxygen species (ROS) generated by dopamine (DA) metabolism. We reported a decrease of GSH levels ([GSH]) in CSF and in prefrontal cortex in vivo in schizophrenics [Eur. J. Neurosci. 12 (2000) 3721]. A GSH deficit may lead to membrane peroxidation and microlesions around dopaminergic terminals, resulting in loss of connectivity. To test this hypothesis, we studied the effect of DA in cultured cortical neurons with low [GSH]. DA alone decreased [GSH] by 40%. This effect appears to result from direct conjugation of DA semiquinone/quinone with GSH. Ethacrynic acid (EA) decreased [GSH] in a concentration-dependent manner. When added to EA, DA further lowers [GSH]. As this additional decrease is blocked by superoxide dismutase (SOD) or D(1)/D(2) receptor antagonists, it likely involves the generation of superoxide via activation of DA receptors. It also reduces the mitochondrial membrane potential. Most interestingly, a significant decrease in number of neuronal processes (spines analogous) was induced by 24-h application of DA only in low [GSH]. These data, compatible with our hypothesis, is consistent with the dendritic spines reduction reported in schizophrenia and could be related to abnormalities in synaptic connectivity.

Citing Articles

Linking Mitochondrial Dysfunction, Neurotransmitter, and Neural Network Abnormalities and Mania: Elucidating Neurobiological Mechanisms of the Therapeutic Effect of the Ketogenic Diet in Bipolar Disorder.

Freyberg Z, Andreazza A, McClung C, Phillips M Biol Psychiatry Cogn Neurosci Neuroimaging. 2024; 10(3):267-277.

PMID: 39053576 PMC: 11754533. DOI: 10.1016/j.bpsc.2024.07.011.


The Underlying Neurobiological Mechanisms of Psychosis: Focus on Neurotransmission Dysregulation, Neuroinflammation, Oxidative Stress, and Mitochondrial Dysfunction.

Rawani N, Chan A, Dursun S, Baker G Antioxidants (Basel). 2024; 13(6).

PMID: 38929148 PMC: 11200831. DOI: 10.3390/antiox13060709.


The potential role of the p75 receptor in schizophrenia: neuroimmunomodulation and making life or death decisions.

Chandra J Brain Behav Immun Health. 2024; 38:100796.

PMID: 38813083 PMC: 11134531. DOI: 10.1016/j.bbih.2024.100796.


Influence of antipsychotic medications on hyperlipidemia risk in patients with schizophrenia: evidence from a population-based cohort study and hepatic lipid homeostasis gene expression.

Wu T, Tien N, Lin C, Cheah Y, Hsu C, Tsai F Front Med (Lausanne). 2023; 10:1137977.

PMID: 37425327 PMC: 10324036. DOI: 10.3389/fmed.2023.1137977.


Schizophrenia Synaptic Pathology and Antipsychotic Treatment in the Framework of Oxidative and Mitochondrial Dysfunction: Translational Highlights for the Clinics and Treatment.

De Simone G, Mazza B, Vellucci L, Barone A, Ciccarelli M, de Bartolomeis A Antioxidants (Basel). 2023; 12(4).

PMID: 37107350 PMC: 10135787. DOI: 10.3390/antiox12040975.